D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 85 Citations 26,751 351 World Ranking 222 National Ranking 110
Medicine D-index 91 Citations 31,676 414 World Ranking 5635 National Ranking 3139

Research.com Recognitions

Awards & Achievements

1968 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Immune system

His primary areas of investigation include Immunology, Transplantation, Interleukin 21, Lymphokine-activated killer cell and Natural killer cell. His studies in Immunology integrate themes in fields like Stem cell and Cell therapy. His Transplantation research integrates issues from Gastroenterology and KIR Ligand.

His Interleukin 21 research is multidisciplinary, relying on both Interleukin 12 and Cell biology. The Lymphokine-activated killer cell study combines topics in areas such as CD16 and B cell. In his study, Cord Blood Stem Cell Transplantation is strongly linked to Umbilical cord, which falls under the umbrella field of Internal medicine.

His most cited work include:

  • Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. (1213 citations)
  • Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. (807 citations)
  • Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy (762 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Immunology, Transplantation, Internal medicine, Cancer research and Interleukin 21. His research in Immunology intersects with topics in Natural killer cell and Stem cell. His Transplantation study which covers Umbilical cord that intersects with Cord Blood Stem Cell Transplantation.

His Internal medicine research incorporates themes from Gastroenterology, Surgery and Oncology. His work in Cancer research addresses subjects such as Interleukin 15, which are connected to disciplines such as Adoptive cell transfer. The study incorporates disciplines such as Interleukin 12 and Cell biology in addition to Interleukin 21.

He most often published in these fields:

  • Immunology (46.03%)
  • Transplantation (27.07%)
  • Internal medicine (22.04%)

What were the highlights of his more recent work (between 2016-2021)?

  • Cancer research (19.29%)
  • Immunology (46.03%)
  • Transplantation (27.07%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Cancer research, Immunology, Transplantation, Internal medicine and Immunotherapy. Jeffrey S. Miller interconnects Cell, Cell therapy, Cytokine, Antibody and Interleukin 15 in the investigation of issues within Cancer research. As part of his studies on Immunology, Jeffrey S. Miller often connects relevant areas like Cytotoxic T cell.

Jeffrey S. Miller has researched Transplantation in several fields, including Leukemia, Human leukocyte antigen and Myeloid leukemia. His Internal medicine study incorporates themes from Gastroenterology and Oncology. Jeffrey S. Miller has included themes like Natural killer cell, Adoptive cell transfer and Ovarian cancer in his Immunotherapy study.

Between 2016 and 2021, his most popular works were:

  • ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial (143 citations)
  • First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation (141 citations)
  • Continuous treatment with IL-15 exhausts human NK cells via a metabolic defect (67 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Immune system

Cancer research, Immunology, Immunotherapy, Immune system and Cell are his primary areas of study. His work deals with themes such as Cell culture, Natural killer cell, Cell therapy, CD16 and Chimeric antigen receptor, which intersect with Cancer research. His work carried out in the field of Immunology brings together such families of science as Cytotoxic T cell and Transplantation.

His Transplantation research is multidisciplinary, incorporating elements of Myeloid, Human leukocyte antigen, Epitope, Leukemia and Haplotype. His biological study spans a wide range of topics, including Interleukin, Cytokine, Interleukin 15 and Ovarian cancer. The various areas that Jeffrey S. Miller examines in his Immune system study include Hematopoietic stem cell transplantation, Myeloid-derived Suppressor Cell and Lymphoma.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer.

Jeffrey S. Miller;Yvette Soignier;Angela Panoskaltsis-Mortari;Sarah A. McNearney.
Blood (2005)

1407 Citations

Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy

Juliet N. Barker;Daniel J. Weisdorf;Todd E. DeFor;Bruce R. Blazar.
Blood (2005)

1023 Citations

Tryptase Levels as an Indicator of Mast-Cell Activation in Systemic Anaphylaxis and Mastocytosis

Lawrence B. Schwartz;Dean D. Metcalfe;Jeffrey S. Miller;Harry Earl.
The New England Journal of Medicine (1987)

966 Citations

Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.

Claudio G. Brunstein;Jeffrey S. Miller;Qing Cao;David H. McKenna.
Blood (2011)

956 Citations

Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia

Sarah Cooley;Daniel J. Weisdorf;Lisbeth A. Guethlein;John P. Klein.
Blood (2010)

568 Citations

Umbilical cord blood transplantation after nonmyeloablative conditioning: Impact on transplantation outcomes in 110 adults with hematologic disease

Claudio G. Brunstein;Juliet N. Barker;Daniel J. Weisdorf;Todd E. DeFor.
Blood (2007)

561 Citations

Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C natural killer cells with potent function

Bree Foley;Sarah Cooley;Michael R. Verneris;Michelle Pitt.
Blood (2012)

541 Citations

Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning.

Juliet N. Barker;Daniel J. Weisdorf;Todd E. DeFor;Bruce R. Blazar.
Blood (2003)

489 Citations

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia

Sarah A Cooley;Elizabeth Trachtenberg;Tracy L. Bergemann;Koy Saeteurn.
Blood (2009)

477 Citations

Malignant neoplasms following bone marrow transplantation.

Smita Bhatia;Norma K.C. Ramsay;Michael Steinbuch;Kathryn E. Dusenbery.
Blood (1996)

450 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Jeffrey S. Miller

Daniel J. Weisdorf

Daniel J. Weisdorf

University of Minnesota

Publications: 138

Bruce R. Blazar

Bruce R. Blazar

University of Minnesota

Publications: 130

Karl-Johan Malmberg

Karl-Johan Malmberg

Oslo University Hospital

Publications: 122

John E. Wagner

John E. Wagner

University of Minnesota

Publications: 102

Franco Locatelli

Franco Locatelli

Bambino Gesù Children's Hospital

Publications: 94

Lorenzo Moretta

Lorenzo Moretta

Bambino Gesù Children's Hospital

Publications: 89

Sergio Giralt

Sergio Giralt

Memorial Sloan Kettering Cancer Center

Publications: 87

Elizabeth J. Shpall

Elizabeth J. Shpall

The University of Texas MD Anderson Cancer Center

Publications: 86

Richard E. Champlin

Richard E. Champlin

The University of Texas MD Anderson Cancer Center

Publications: 77

Hillard M. Lazarus

Hillard M. Lazarus

Case Western Reserve University

Publications: 72

Joseph H. Antin

Joseph H. Antin

Harvard University

Publications: 70

Eliane Gluckman

Eliane Gluckman

Université Paris Cité

Publications: 69

Michael A. Caligiuri

Michael A. Caligiuri

City Of Hope National Medical Center

Publications: 66

Dean A. Lee

Dean A. Lee

Nationwide Children's Hospital

Publications: 64

Peter Valent

Peter Valent

Medical University of Vienna

Publications: 61

Mary M. Horowitz

Mary M. Horowitz

Center for International Blood and Marrow Transplant Research

Publications: 60

Trending Scientists

Qiuwei Wu

Qiuwei Wu

Technical University of Denmark

Jay Lee

Jay Lee

Korea Advanced Institute of Science and Technology

Benny Lo

Benny Lo

Imperial College London

Yossi Rosenwaks

Yossi Rosenwaks

Tel Aviv University

Richard A. Phillips

Richard A. Phillips

Natural Environment Research Council

Sofia Noemi Chulze

Sofia Noemi Chulze

National University of Río Cuarto

Masayoshi Kawaguchi

Masayoshi Kawaguchi

National Institute for Basic Biology

Nicole Stoesser

Nicole Stoesser

University of Oxford

Robert A. Cramer

Robert A. Cramer

Dartmouth College

E Y Jones

E Y Jones

University of Oxford

Xiaoping Wang

Xiaoping Wang

Chinese Academy of Sciences

Daniel W. Russell

Daniel W. Russell

Iowa State University

Malcolm Lader

Malcolm Lader

King's College London

Richard L. Verrier

Richard L. Verrier

Beth Israel Deaconess Medical Center

Brigitte Nerlich

Brigitte Nerlich

University of Nottingham

John Skvoretz

John Skvoretz

University of South Florida

Something went wrong. Please try again later.